["(S1 (S (S (NP (NP (NN Inhibition|0|10)) (PP (IN of|11|13) (NP (NN microRNA-17|14|25)))) (VP (VBZ improves|26|34) (NP (NP (NP (NN lung|35|39)) (CC and|40|43) (NP (NN heart|44|49))) (NN function|50|58)) (PP (IN in|59|61) (NP (JJ experimental|62|74) (JJ pulmonary|75|84) (NN hypertension|85|97))))) (. .|97|98)))", "(S1 (S (NP (NP (NN RATIONALE|99|108)) (: :|108|109) (S (NP (NP (NNS MicroRNAs|110|119)) (PRN (-LRB- -LRB-|120|121) (NP (NNS miRs|121|125)) (-RRB- -RRB-|125|126))) (VP (VBP control|127|134) (NP (NP (JJ various|135|142) (JJ cellular|143|151) (NNS processes|152|161)) (PP (IN in|59|61) (NP (NP (NN tissue|165|171) (NN homeostasis|172|183)) (CC and|40|43) (NP (NN disease|188|195))))) (PP (IN by|196|198) (S (VP (VBG regulating|199|209) (NP (NP (NN gene|210|214) (NN expression|215|225)) (PP (IN on|56|58) (NP (DT the|229|232) (JJ posttranscriptional|233|252) (NN level|253|258))))))))) (. .|97|98))))", "(S1 (S (S (ADVP (RB Recently|260|268)) (, ,|268|269) (NP (PRP it|270|272)) (VP (VBD was|273|276) (VP (VBN demonstrated|277|289) (SBAR (IN that|290|294) (S (NP (NP (DT the|229|232) (NN expression|215|225)) (PP (IN of|310|312) (NP (NP (NN miR-21|313|319)) (CC and|184|187) (NP (NP (NNS members|324|331)) (PP (IN of|310|312) (NP (DT the|229|232) (NN miR-17-92|339|348) (NN cluster|349|356))))))) (VP (VBD was|273|276) (ADVP (RB significantly|361|374)) (VP (VBN altered|375|382) (PP (IN in|59|61) (NP (NP (JJ experimental|62|74) (JJ pulmonary|75|84) (NN hypertension|85|97)) (PRN (-LRB- -LRB-|120|121) (NP (NN PH|423|425)) (-RRB- -RRB-|125|126))))))))))) (. .|97|98)))", "(S1 (S (NP (NP (NNS OBJECTIVES|429|439)) (: :|108|109) (S (VP (TO To|441|443) (VP (VB evaluate|444|452) (NP (NP (DT the|229|232) (NP (JJ therapeutic|457|468) (NN efficacy|469|477)) (CC and|184|187) (NP (JJ antiremodeling|482|496) (NN potential|497|506))) (PP (IN of|310|312) (NP (NN miR|121|124) (NNS inhibitors|514|524))) (PP (IN in|162|164) (NP (NP (DT the|229|232) (NN pathogenesis|532|544)) (PP (IN of|310|312) (NP (NN PH|423|425))))))))) (. .|97|98))))", "(S1 (S (NP (NP (NNS METHODS|552|559)) (: :|108|109) (S (NP (PRP We|561|563)) (ADVP (RB first|564|569)) (VP (VBD tested|570|576) (NP (NP (DT the|229|232) (NNS effects|581|588)) (PP (IN of|310|312) (NP (NP (NN miR|121|124) (NNS inhibitors|514|524)) (PRN (-LRB- -LRB-|120|121) (NP (NNS antagomirs|608|618)) (-RRB- -RRB-|125|126)))) (, ,|268|269) (SBAR (WHNP (WDT which|621|626)) (S (VP (VBD were|627|631) (ADVP (RB specifically|632|644)) (VP (VBN designed|645|653) (S (VP (TO to|520|522) (VP (VB block|657|662) (NP (NP (NP (NN miR-17|339|345)) (PRN (-LRB- -LRB-|120|121) (NP (NN A-17|671|675)) (-RRB- -RRB-|125|126))) (, ,|268|269) (NP (NP (NN miR-21|313|319)) (PRN (-LRB- -LRB-|120|121) (NP (NN A-21|686|690)) (-RRB- -RRB-|125|126))) (, ,|268|269) (CC and|184|187) (NP (NP (NN miR-92a|697|704)) (PRN (-LRB- -LRB-|120|121) (NP (NN A-92a|706|711)) (-RRB- -RRB-|125|126)))) (PP (IN in|162|164) (NP (NP (NP (JJ chronic|716|723) (JJ hypoxia-induced|724|739) (NN PH|423|425)) (PP (IN in|162|164) (NP (NNS mice|746|750)))) (CC and|184|187) (NP (NP (NN A-17|671|675)) (PP (IN in|162|164) (NP (NP (JJ monocrotaline-induced|763|784) (NN PH|423|425)) (PP (IN in|162|164) (NP (NNS rats|791|795)))))))))))))))))) (. .|258|259))))", "(S1 (S (S (ADVP (RB Moreover|797|805)) (, ,|268|269) (NP (NP (JJ biological|807|817) (NN function|818|826)) (PP (IN of|310|312) (NP (NN miR-17|339|345)))) (VP (VBD was|273|276) (VP (VBN analyzed|841|849) (PP (IN in|162|164) (NP (VBN cultured|853|861) (JJ pulmonary|399|408) (NN artery|872|878) (NN smooth|879|885) (NN muscle|886|892) (NNS cells|893|898)))))) (. .|258|259)))", "(S1 (S (NP (NP (NP (NNS MEASUREMENTS|900|912)) (CC AND|913|916) (NP (JJ MAIN|917|921) (NNS RESULTS|922|929))) (: :|439|440) (S (PP (IN In|931|933) (NP (DT the|229|232) (NN PH|423|425) (NN mouse|941|946) (NN model|488|493))) (, ,|268|269) (S (NP (NP (NN A-17|671|675)) (CC and|184|187) (NP (NN A-21|686|690))) (VP (VBD reduced|968|975) (NP (JJ right|976|981) (JJ ventricular|982|993) (JJ systolic|994|1002) (NN pressure|1003|1011)))) (, ,|268|269) (CC and|184|187) (S (NP (DT all|640|643) (NNS antagomirs|608|618)) (VP (VBD decreased|1032|1041) (NP (JJ pulmonary|399|408) (JJ arterial|1052|1060) (NN muscularization|1061|1076))))) (. .|258|259))))", "(S1 (S (ADVP (RB However|1078|1085)) (, ,|268|269) (NP (JJ only|1087|1091) (NN A-17|671|675)) (VP (VP (VBD reduced|968|975) (NP (JJ hypoxia-induced|724|739) (JJ right|976|981) (NN ventricular|982|993) (NN hypertrophy|1139|1150))) (CC and|320|323) (VP (VBD improved|1155|1163) (NP (JJ pulmonary|399|408) (NN artery|872|878) (NN acceleration|1181|1193) (NN time|1194|1198)))) (. .|258|259)))", "(S1 (S (S (PP (IN In|931|933) (NP (DT the|229|232) (JJ monocrotaline-induced|763|784) (NN PH|423|425) (NN rat|284|287) (NN model|488|493))) (, ,|268|269) (NP (NN A-17|671|675) (NN treatment|1248|1257)) (ADVP (RB significantly|361|374)) (VP (VBD decreased|1032|1041) (NP (NP (NP (JJ right|976|981) (JJ ventricular|982|993) (JJ systolic|994|1002) (NN pressure|1003|1011)) (CC and|320|323) (NP (JJ total|1322|1327) (JJ pulmonary|399|408) (JJ vascular|1338|1346) (NN resistance|1347|1357)) (NP (NN index|1358|1363))) (, ,|268|269) (NP (VBN increased|1365|1374) (JJ pulmonary|399|408) (NN artery|872|878) (NN acceleration|1181|1193) (NN time|1194|1198)) (, ,|268|269) (NP (VBN normalized|1411|1421) (JJ cardiac|1422|1429) (NN output|1430|1436)) (, ,|268|269) (CC and|320|323) (NP (VBN decreased|1032|1041) (JJ pulmonary|399|408) (JJ vascular|1338|1346) (NN remodeling|486|496))))) (. .|258|259)))", "(S1 (S (S (PP (IN Among|1483|1488) (NP (DT the|295|298) (VBN tested|570|576) (NN miR-17|339|345) (NNS targets|1507|1514))) (, ,|268|269) (NP (DT the|295|298) (JJ cyclin-dependent|1520|1536) (NN kinase|1537|1543) (NN inhibitor|514|523) (NN 1A|1554|1556) (-LRB- -LRB-|422|423) (NN p21|1558|1561) (-RRB- -RRB-|425|426)) (VP (VBD was|273|276) (VP (VBN up-regulated|1567|1579) (PP (IN in|383|385) (NP (NP (NNS lungs|1583|1588)) (VP (VBG undergoing|1589|1599) (NP (NN A-17|671|675) (NN treatment|1248|1257)))))))) (. .|258|259)))", "(S1 (S (S (ADVP (RB Likewise|1616|1624)) (, ,|268|269) (PP (IN in|383|385) (NP (JJ human|1629|1634) (JJ pulmonary|399|408) (NN artery|872|878) (NN smooth|879|885) (NN muscle|886|892) (NNS cells|893|898))) (, ,|268|269) (NP (NN A-17|671|675)) (VP (VBD increased|1365|1374) (NP (NN p21|1558|1561)))) (. .|427|428)))", "(S1 (S (S (NP (NP (NN Overexpression|1694|1708)) (PP (IN of|310|312) (NP (NN miR-17|339|345)))) (ADVP (RB significantly|361|374)) (VP (VP (VBD reduced|968|975) (NP (NN p21|1558|1561) (NN expression|299|309))) (CC and|320|323) (VP (VBD increased|1365|1374) (NP (NP (NN proliferation|1770|1783)) (PP (IN of|310|312) (NP (NN smooth|879|885) (NN muscle|886|892) (NNS cells|893|898))))))) (. .|427|428)))", "(S1 (S (NP (NP (NNS CONCLUSIONS|1808|1819)) (: :|439|440) (S (NP (PRP$ Our|1821|1824) (NNS data|1825|1829)) (VP (VBP demonstrate|1830|1841) (SBAR (IN that|290|294) (S (NP (NN A-17|671|675)) (VP (VBZ improves|1852|1860) (NP (NP (NP (NN heart|1861|1866)) (CC and|320|323) (NP (NN lung|1583|1587))) (NN function|818|826)) (PP (IN in|383|385) (NP (JJ experimental|386|398) (NN PH|423|425))) (PP (IN by|1904|1906) (S (VP (VBG interfering|1907|1918) (PP (IN with|1919|1923) (NP (NN lung|1583|1587) (ADJP (ADJP (JJ vascular|1338|1346)) (CC and|320|323) (ADJP (JJ right|976|981))) (NN ventricular|982|993) (NN remodeling|486|496))))))))))) (. .|427|428))))", "(S1 (S (S (NP (DT The|1972|1975) (JJ beneficial|1976|1986) (NNS effects|581|588)) (VP (MD may|1995|1998) (VP (VB be|327|329) (ADJP (JJ related|2002|2009) (PP (TO to|520|522) (NP (NP (DT the|335|338) (NN up-regulation|2017|2030)) (PP (IN of|332|334) (NP (NN p21|1558|1561))))))))) (. .|427|428)))", "(S1 (S (S (ADVP (RB Thus|2040|2044)) (, ,|619|620) (NP (NP (NN inhibition|2046|2056)) (PP (IN of|332|334) (NP (NN miR-17|339|345)))) (VP (MD may|1995|1998) (VP (VB represent|2071|2080) (NP (NP (DT a|358|359) (ADJP (ADJP (JJ novel|2083|2088)) (ADJP (JJ therapeutic|457|468))) (NN concept|2101|2108)) (S (VP (TO to|520|522) (VP (VB ameliorate|2112|2122) (NP (NP (NN disease|2123|2130) (NN state|2131|2136)) (PP (IN in|383|385) (NP (NN PH|423|425))))))))))) (. .|427|428)))"]